NCT05080062

Brief Summary

Requirements and functional Schedule also calen Demand Ability Protocol (DAP) is an intervention that has been tested and found useful in occupational health service. The intervention aims to strengthen the collaboration between Health care, employers and employee. The intervention is based on a structured interview about the employers demands at work. This intervention (DAP) will in the present study be evaluated in pain rehabilitation both qualitatively and quantitatively.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable chronic-pain

Timeline
Completed

Started Jun 2019

Longer than P75 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2019

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

July 16, 2019

Completed
2.3 years until next milestone

First Posted

Study publicly available on registry

October 15, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2023

Completed
Last Updated

November 8, 2021

Status Verified

October 1, 2021

Enrollment Period

3.5 years

First QC Date

July 16, 2019

Last Update Submit

October 29, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Absence from work (sickleave) measured with a question to the participants

    Less absence from work

    Changes from baseline in absence from work to the end of the rehab program (average 4month)

  • Absence from work (sickleave) measured with a question to the participants

    Less absence from work

    Changes from baseline in absence from work through study completion (average 1,5 years)

Secondary Outcomes (12)

  • Changes in EuroQol 5-dimensions questionnaire (EQ-5D)

    Change from baseline in EuroQol 5-dimensions through study completion (average 1,5 years)

  • Changes in EuroQol 5-dimensions

    Change from baseline in EuroQol 5-dimensions to the end of the rehab program (average foru month)

  • Changes in Anxiety and depression

    Change from baseline in anxiety and depression through study completion (average 1,5 years)hs)

  • Changes in Anxiety and depression

    Change from baseline in anxiety and depression to the end of the rehab program (average four month)

  • Changes in sleep

    Change from baseline in Insomnia Severity Index to the end of the rehab program (average four month)

  • +7 more secondary outcomes

Study Arms (2)

Painrehabilitation + Demand and ability protocol

EXPERIMENTAL

Will receive pain-rehabilitation and the intervention ( an interview called Requirements and functional Schedule, with the patients employer and an occupational therapist)

Behavioral: Requirements and functional Schedule

Painrehabilitation

ACTIVE COMPARATOR

Will receive pain-rehabilitation

Behavioral: No intervention

Interventions

An interview with the employee and the employer where the occupational worker is leading the interview and a pain rehabilitation-program

Painrehabilitation + Demand and ability protocol
No interventionBEHAVIORAL

a pain rehabilitation-program

Painrehabilitation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic pain, has an employment

You may not qualify if:

  • no longer than 6 month of total sick-leave

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Katarina Danielsson

Uppsala, 75239, Sweden

RECRUITING

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Therese Hellman, PhD

    Uppsala University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: 50 patients who are in painrehabilitation will also receive the intervention. The control Group will be based on patients from 2017 and 2018 who has underwent rehabilitation. This data will be extracted from the National register of pain rehabilitation in Sweden.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief physician, principal investigator

Study Record Dates

First Submitted

July 16, 2019

First Posted

October 15, 2021

Study Start

June 20, 2019

Primary Completion

December 20, 2022

Study Completion

December 20, 2023

Last Updated

November 8, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations